Advertisement Capsugel opens dosage form solutions business unit - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Capsugel opens dosage form solutions business unit

Capsugel, a provider of dosage forms and solutions for the healthcare industry, has opened a new dosage form solutions (DFS) business unit.

The DFS unit will leverage the company’s proprietary technology platforms including lipid-based formulations and targeted release capsule formulation, R&D capabilities and commercial manufacturing infrastructure to develop and manufacture targeted release capsules for customers.

The platforms are used to improve bioavailability, optimal dosing for potent APIs, controlled release, stability and taste masking of various solid oral dosage product, according to Capsugel

Capsugel president and CEO Guido Driesen said, "With the launch of the new DFS business unit, Capsugel builds on its heritage of delivering innovative, quality products and services in hard capsules, by advancing our expertise in product formulation and commercial finished product manufacturing."

Capsugel has also announced that Amit Patel, from the company’s headquarters in Morristown, New Jersey, US, will serve as president of DFS business unit.